Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?-Reference-Cited by-同舟云学术

Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?

Published:2014-08 Issue:4 Volume:16 Page:
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

van Baarsen Lisa GM,Lebre Maria C,van der Coelen Dennis,Aarrass Saïda,Tang Man W,Ramwadhdoebe Tamara H,Gerlag Daniëlle M,Tak Paul P

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1186/s13075-014-0426-z.pdf

Reference49 articles.

1. Miossec P, Korn T, Kuchroo VK: Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009, 361: 888-898. 10.1056/NEJMra0707449.

2. Annunziato F, Romagnani S: The transient nature of the Th17 phenotype. Eur J Immunol. 2010, 40: 3312-3316. 10.1002/eji.201041145.

3. Muranski P, Restifo NP: Essentials of Th17 cell commitment and plasticity. Blood. 2013, 121: 2402-2414. 10.1182/blood-2012-09-378653.

4. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, Evans JG, Cimaz R, Bajaj-Elliott M, Wedderburn LR: Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A. 2010, 107: 14751-14756. 10.1073/pnas.1003852107.

5. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005, 6: 1123-1132. 10.1038/ni1254.

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of IL-17F rs763780 polymorphism and risk of psoriasis in Turkish population: a case-control study;Anais Brasileiros de Dermatologia;2024-05

2. Relation of cytokine profile and antibody values to post-translational protein modifications in patients with rheumatoid arthritis (preliminary data);Rheumatology Science and Practice;2024-04-28

3. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis;Arthritis & Rheumatology;2024-03-04

4. Expanding the Psoriasis Framework: Immunopathogenesis and Treatment Updates;Cutis;2024-02-01

5. Role of Interleukin-17 family cytokines in disease severity of patients with knee osteoarthritis;Advances in Rheumatology;2024-01-24